- In May 2023, Merit Medical Systems, Inc. acquired the BioSentry® Biopsy Tract Sealant System and several dialysis catheter devices from AngioDynamics, Inc. for $100 million in cash. Additionally, Merit Medical made a $32.5 million cash payment to Bluegrass Vascular Technologies, Inc. for the Surfacer® Inside-Out® Access Catheter System. These strategic acquisitions are aimed at expanding Merit’s portfolio in the vascular and biopsy tract management sectors
- In June 2023, Terumo Aortic launched its global Post-Approval Study (PAS), known as EXTEND, which centers on the Thoraflex Hybrid device. This device is the only Frozen Elephant Trunk (FET) device approved by the US Food and Drug Administration (FDA) for treating patients with complex aortic arch diseases. The study aims to further evaluate the device's effectiveness and long-term outcomes in this patient population
- In December 2022, Sirtex Medical and Grand Pharmaceutical Group Limited received approval from the Chinese National Medical Products Administration for their SIR-Spheres® Y-90 resin microspheres. This milestone marked the first successful selective internal radiation therapy (SIRT) procedure using SIR-Spheres in China. The approval opens up new opportunities for the treatment of liver cancer patients in the region using this advanced therapy
